Our research department is a leader in conducting state-of-the-art trials for neurological disorders.
Since 2002, we have participated in the approval process of safe and effective treatments for those diagnosed with epilepsy, migraines, and other neurological disorders.
We look forward to discussing our current studies with you to determine if you or your child meet eligibility criteria.
ACTIVELY ENROLLING STUDIES
New-Onset or Recent-Onset Epilepsy– POS (with or without 2nd gen) or PGTCS
Ages: 2 – 15 years old
Generalized/Secondary Generalized/Mixed Seizures
Ages: 1 month – <18 years old
Primary Generalized Tonic-Clonic
Ages: 5 – 65 years old
Partial Onset Seizure
Ages: 1 month – 17 years old
Upper or Lower Limb Spasticity
Ages: 2 – <17 years old
Stable monoplegic, hemiplegic, or triplegic
Ages: 2 – 18 years old
Glut 1 Deficiency
Ages: 1- <35 years old
Ages: Children and adolescents, 6-16 years old
Any Epilepsy Type
Ages: 1 month to less than 24 months old
For more information, please contact:
Phone: 407.293.1122, ext. 226